Proceedings of the 2021 3rd International Conference on Literature, Art and Human Development (ICLAHD 2021)

Cancer Drugs in China: Unaffordability and Policy Solutions

Authors
Yining Liuangelayn@ad.unc.edu
University of North Carolina at Chapel Hill
Corresponding Author
Available Online 29 November 2021.
DOI
10.2991/assehr.k.211120.092How to use a DOI?
Keywords
cancer drug; China; affordability; policy; human welfare
Abstract

The high cost and unaffordability of cancer drugs present serious challenges to treatment access and cancer outcomes. This issue is particularly salient in developing countries, where health care provision is limited and patients are themselves responsible for a large portion of treatment costs. What are the various reasons for the high cost of cancer drugs? How do different countries respond to this challenge differently? What policies are already in place to address this challenge, and what additional issues remain to be addressed in the long term? This paper discusses these topics in the context of China through an economic and public-policy lens and suggests a few long-term solutions.

Copyright
© 2021 The Authors. Published by Atlantis Press SARL.
Open Access
This is an open access article under the CC BY-NC license.

Download article (PDF)

Volume Title
Proceedings of the 2021 3rd International Conference on Literature, Art and Human Development (ICLAHD 2021)
Series
Advances in Social Science, Education and Humanities Research
Publication Date
29 November 2021
ISBN
978-94-6239-461-2
ISSN
2352-5398
DOI
10.2991/assehr.k.211120.092How to use a DOI?
Copyright
© 2021 The Authors. Published by Atlantis Press SARL.
Open Access
This is an open access article under the CC BY-NC license.

Cite this article

TY  - CONF
AU  - Yining Liu
PY  - 2021
DA  - 2021/11/29
TI  - Cancer Drugs in China: Unaffordability and Policy Solutions
BT  - Proceedings of the 2021 3rd International Conference on Literature, Art and Human Development (ICLAHD 2021)
PB  - Atlantis Press
SP  - 484
EP  - 488
SN  - 2352-5398
UR  - https://doi.org/10.2991/assehr.k.211120.092
DO  - 10.2991/assehr.k.211120.092
ID  - Liu2021
ER  -